1
|
Li X, Quan M, Wei Y, Wang W, Xu L, Wang Q, Jia J. Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective. SCIENCE CHINA. LIFE SCIENCES 2023; 66:2711-2754. [PMID: 37480469 DOI: 10.1007/s11427-022-2357-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2022] [Accepted: 04/23/2023] [Indexed: 07/24/2023]
Abstract
Transgenic models are useful tools for studying the pathogenesis of and drug development for Alzheimer's Disease (AD). AD models are constructed usually using overexpression or knock-in of multiple pathogenic gene mutations from familial AD. Each transgenic model has its unique behavioral and pathological features. This review summarizes the research progress of transgenic mouse models, and their progress in the unique mechanism of amyloid-β oligomers, including the first transgenic mouse model built in China based on a single gene mutation (PSEN1 V97L) found in Chinese familial AD. We further summarized the preclinical findings of drugs using the models, and their future application in exploring the upstream mechanisms and multitarget drug development in AD.
Collapse
Affiliation(s)
- Xinyue Li
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
| | - Meina Quan
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
- National Medical Center for Neurological Diseases and National Clinical Research Center for Geriatric Diseases, Beijing, 100053, China
| | - Yiping Wei
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
| | - Wei Wang
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
- National Medical Center for Neurological Diseases and National Clinical Research Center for Geriatric Diseases, Beijing, 100053, China
| | - Lingzhi Xu
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
| | - Qi Wang
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
- National Medical Center for Neurological Diseases and National Clinical Research Center for Geriatric Diseases, Beijing, 100053, China
| | - Jianping Jia
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
- National Medical Center for Neurological Diseases and National Clinical Research Center for Geriatric Diseases, Beijing, 100053, China.
- Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, 100053, China.
- Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, 100053, China.
- Center of Alzheimer's Disease, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, 100053, China.
- Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, 100053, China.
| |
Collapse
|
3
|
Quan M, Wang Q, Qin W, Wang W, Li F, Zhao T, Li T, Qiu Q, Cao S, Wang S, Wang Y, Jin H, Zhou A, Fang J, Jia L, Jia J. Shared and unique effects of ApoEε4 and pathogenic gene mutation on cognition and imaging in preclinical familial Alzheimer's disease. Alzheimers Res Ther 2023; 15:40. [PMID: 36850008 PMCID: PMC9972804 DOI: 10.1186/s13195-023-01192-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2022] [Accepted: 02/13/2023] [Indexed: 03/01/2023]
Abstract
BACKGROUND Neuropsychology and imaging changes have been reported in the preclinical stage of familial Alzheimer's disease (FAD). This study investigated the effects of APOEε4 and known pathogenic gene mutation on different cognitive domains and circuit imaging markers in preclinical FAD. METHODS One hundred thirty-nine asymptomatic subjects in FAD families, including 26 APOEε4 carriers, 17 APP and 20 PS1 mutation carriers, and 76 control subjects, went through a series of neuropsychological tests and MRI scanning. Test scores and imaging measures including volumes, diffusion indices, and functional connectivity (FC) of frontostriatal and hippocampus to posterior cingulate cortex pathways were compared between groups and analyzed for correlation. RESULTS Compared with controls, the APOEε4 group showed increased hippocampal volume and decreased FC of fronto-caudate pathway. The APP group showed increased recall scores in auditory verbal learning test, decreased fiber number, and increased radial diffusivity and FC of frontostriatal pathway. All three genetic groups showed decreased fractional anisotropy of hippocampus to posterior cingulate cortex pathway. These neuropsychological and imaging measures were able to discriminate genetic groups from controls, with areas under the curve from 0.733 to 0.837. Circuit imaging measures are differentially associated with scores in various cognitive scales in control and genetic groups. CONCLUSIONS There are neuropsychological and imaging changes in the preclinical stage of FAD, some of which are shared by APOEε4 and known pathogenic gene mutation, while some are unique to different genetic groups. These findings are helpful for the early identification of Alzheimer's disease and for developing generalized and individualized prevention and intervention strategies.
Collapse
Affiliation(s)
- Meina Quan
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Qi Wang
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Wei Qin
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Wei Wang
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Fangyu Li
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Tan Zhao
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China
| | - Tingting Li
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Qiongqiong Qiu
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Shuman Cao
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Shiyuan Wang
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Yan Wang
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Hongmei Jin
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Aihong Zhou
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Jiliang Fang
- grid.464297.aGuang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
| | - Longfei Jia
- grid.413259.80000 0004 0632 3337Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China ,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China ,grid.24696.3f0000 0004 0369 153XClinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China ,grid.24696.3f0000 0004 0369 153XBeijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China ,grid.24696.3f0000 0004 0369 153XCenter of Alzheimer’s Disease, Beijing Institute for Brain Disorders, Beijing, China ,grid.419897.a0000 0004 0369 313XKey Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China
| | - Jianping Jia
- Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. .,National Center for Neurological Disorders and National Clinical Research Center for Geriatric Diseases, Beijing, China. .,Clinical Center for Neurodegenerative Disease and Memory Impairment, Capital Medical University, Beijing, China. .,Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, China. .,Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, China. .,Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, China.
| |
Collapse
|
5
|
Russo M, Santilli M, De Rosa MA, Calisi D, Dono F, Mattoli MV, Bonanni L, Onofrj M, Sensi SL. A Young Man with Cognitive Impairment and a Heart Condition. J Alzheimers Dis 2022; 89:405-410. [DOI: 10.3233/jad-220528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
A 43-year-old came to our observation for progressive cognitive impairment, confirmed by the neuropsychological evaluation. A diagnosis of multidomain amnestic mild cognitive impairment, due to unknown reasons, was posited at the first assessment. The patient’s neurological exam was otherwise completely normal. The patient’s mother was clinically diagnosed with frontotemporal dementia in her forties. The patient underwent neuroimaging investigations and cerebrospinal fluid analysis. Our diagnostic work-up pointed toward a neurodegenerative etiology, but the presence of concurrent cardiomyopathy emerged in the meantime. Due to the patient’s family history, a thorough genetic screening was performed. The results revealed a unique genetic asset, with heterozygotic variants of three amyloid-related genes (PSEN1, APP, and MYBPC3). PSEN1 and MYBPC3 mutations showed distinct pathogenic features and accounted for the patient’s brain and cardiac amyloidosis, whereas the APP variant was of uncertain pathological implications.
Collapse
Affiliation(s)
- Mirella Russo
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- CAST –Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Matteo Santilli
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- CAST –Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Matteo A. De Rosa
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- CAST –Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Dario Calisi
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- CAST –Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Fedele Dono
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- CAST –Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Maria Vittoria Mattoli
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Nuclear Medicine Unit, Ospedale Santo Spirito, Pescara, Italy
| | - Laura Bonanni
- Department of Medicine and Aging Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Marco Onofrj
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- CAST –Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Stefano L. Sensi
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- CAST –Center for Advanced Studies and Technology, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- ITAB –Institute for Advanced Biomedical Technologies, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| |
Collapse
|
7
|
Ghafouri F, Bahrami A, Sadeghi M, Miraei-Ashtiani SR, Bakherad M, Barkema HW, Larose S. Omics Multi-Layers Networks Provide Novel Mechanistic and Functional Insights Into Fat Storage and Lipid Metabolism in Poultry. Front Genet 2021; 12:646297. [PMID: 34306005 PMCID: PMC8292821 DOI: 10.3389/fgene.2021.646297] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2020] [Accepted: 06/04/2021] [Indexed: 12/25/2022] Open
Abstract
Fatty acid metabolism in poultry has a major impact on production and disease resistance traits. According to the high rate of interactions between lipid metabolism and its regulating properties, a holistic approach is necessary. To study omics multilayers of adipose tissue and identification of genes and miRNAs involved in fat metabolism, storage and endocrine signaling pathways in two groups of broiler chickens with high and low abdominal fat, as well as high-throughput techniques, were used. The gene–miRNA interacting bipartite and metabolic-signaling networks were reconstructed using their interactions. In the analysis of microarray and RNA-Seq data, 1,835 genes were detected by comparing the identified genes with significant expression differences (p.adjust < 0.01, fold change ≥ 2 and ≤ −2). Then, by comparing between different data sets, 34 genes and 19 miRNAs were detected as common and main nodes. A literature mining approach was used, and seven genes were identified and added to the common gene set. Module finding revealed three important and functional modules, which were involved in the peroxisome proliferator-activated receptor (PPAR) signaling pathway, biosynthesis of unsaturated fatty acids, Alzheimer’s disease metabolic pathway, adipocytokine, insulin, PI3K–Akt, mTOR, and AMPK signaling pathway. This approach revealed a new insight to better understand the biological processes associated with adipose tissue.
Collapse
Affiliation(s)
- Farzad Ghafouri
- Department of Animal Science, College of Agriculture and Natural Resources, University of Tehran, Karaj, Iran
| | - Abolfazl Bahrami
- Department of Animal Science, College of Agriculture and Natural Resources, University of Tehran, Karaj, Iran.,Biomedical Center for Systems Biology Science Munich, Ludwig-Maximilians-University, Munich, Germany
| | - Mostafa Sadeghi
- Department of Animal Science, College of Agriculture and Natural Resources, University of Tehran, Karaj, Iran
| | - Seyed Reza Miraei-Ashtiani
- Department of Animal Science, College of Agriculture and Natural Resources, University of Tehran, Karaj, Iran
| | - Maryam Bakherad
- Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
| | - Herman W Barkema
- Department of Production Animal Health, University of Calgary, Calgary, AB, Canada
| | - Samantha Larose
- One Health at UCalgary, University of Calgary, Calgary, AB, Canada
| |
Collapse
|